Global Structural Heart Disease Interventional Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 104

Published Date: 01 Jun 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Structural Heart Disease Interventional Therapy market size was valued at USD 13920 million in 2022 and is forecast to a readjusted size of USD 27720 million by 2029 with a CAGR of 10.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Structural heart disease refers to any abnormality in the structure of the heart, any disease involving the structure of the heart and great vessels
This report is a detailed and comprehensive analysis for global Structural Heart Disease Interventional Therapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Structural Heart Disease Interventional Therapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Structural Heart Disease Interventional Therapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Structural Heart Disease Interventional Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Structural Heart Disease Interventional Therapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Structural Heart Disease Interventional Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Structural Heart Disease Interventional Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Structural Heart, philips, Japen Lifeline, Neovasc and Append Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Structural Heart Disease Interventional Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Equipment
    Consumables

Market segment by Application
    Hospital
    Clinic
    Others

Major players covered
    Abbott Structural Heart
    philips
    Japen Lifeline
    Neovasc
    Append Medical
    Transverse Medical
    Cardiomech
    Thubrikar Aortic Valve Inc.
    boston scientific
    Edwards Lifesciences Corporation
    Biomerics
    LivaNova PLC

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Structural Heart Disease Interventional Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Structural Heart Disease Interventional Therapy, with price, sales, revenue and global market share of Structural Heart Disease Interventional Therapy from 2018 to 2023.
Chapter 3, the Structural Heart Disease Interventional Therapy competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Structural Heart Disease Interventional Therapy breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Structural Heart Disease Interventional Therapy market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Structural Heart Disease Interventional Therapy.
Chapter 14 and 15, to describe Structural Heart Disease Interventional Therapy sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Structural Heart Disease Interventional Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Structural Heart Disease Interventional Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Equipment
        1.3.3 Consumables
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Structural Heart Disease Interventional Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Others
    1.5 Global Structural Heart Disease Interventional Therapy Market Size & Forecast
        1.5.1 Global Structural Heart Disease Interventional Therapy Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Structural Heart Disease Interventional Therapy Sales Quantity (2018-2029)
        1.5.3 Global Structural Heart Disease Interventional Therapy Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Abbott Structural Heart
        2.1.1 Abbott Structural Heart Details
        2.1.2 Abbott Structural Heart Major Business
        2.1.3 Abbott Structural Heart Structural Heart Disease Interventional Therapy Product and Services
        2.1.4 Abbott Structural Heart Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Abbott Structural Heart Recent Developments/Updates
    2.2 philips
        2.2.1 philips Details
        2.2.2 philips Major Business
        2.2.3 philips Structural Heart Disease Interventional Therapy Product and Services
        2.2.4 philips Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 philips Recent Developments/Updates
    2.3 Japen Lifeline
        2.3.1 Japen Lifeline Details
        2.3.2 Japen Lifeline Major Business
        2.3.3 Japen Lifeline Structural Heart Disease Interventional Therapy Product and Services
        2.3.4 Japen Lifeline Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Japen Lifeline Recent Developments/Updates
    2.4 Neovasc
        2.4.1 Neovasc Details
        2.4.2 Neovasc Major Business
        2.4.3 Neovasc Structural Heart Disease Interventional Therapy Product and Services
        2.4.4 Neovasc Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Neovasc Recent Developments/Updates
    2.5 Append Medical
        2.5.1 Append Medical Details
        2.5.2 Append Medical Major Business
        2.5.3 Append Medical Structural Heart Disease Interventional Therapy Product and Services
        2.5.4 Append Medical Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Append Medical Recent Developments/Updates
    2.6 Transverse Medical
        2.6.1 Transverse Medical Details
        2.6.2 Transverse Medical Major Business
        2.6.3 Transverse Medical Structural Heart Disease Interventional Therapy Product and Services
        2.6.4 Transverse Medical Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Transverse Medical Recent Developments/Updates
    2.7 Cardiomech
        2.7.1 Cardiomech Details
        2.7.2 Cardiomech Major Business
        2.7.3 Cardiomech Structural Heart Disease Interventional Therapy Product and Services
        2.7.4 Cardiomech Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Cardiomech Recent Developments/Updates
    2.8 Thubrikar Aortic Valve Inc.
        2.8.1 Thubrikar Aortic Valve Inc. Details
        2.8.2 Thubrikar Aortic Valve Inc. Major Business
        2.8.3 Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Product and Services
        2.8.4 Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Thubrikar Aortic Valve Inc. Recent Developments/Updates
    2.9 boston scientific
        2.9.1 boston scientific Details
        2.9.2 boston scientific Major Business
        2.9.3 boston scientific Structural Heart Disease Interventional Therapy Product and Services
        2.9.4 boston scientific Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 boston scientific Recent Developments/Updates
    2.10 Edwards Lifesciences Corporation
        2.10.1 Edwards Lifesciences Corporation Details
        2.10.2 Edwards Lifesciences Corporation Major Business
        2.10.3 Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Product and Services
        2.10.4 Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Edwards Lifesciences Corporation Recent Developments/Updates
    2.11 Biomerics
        2.11.1 Biomerics Details
        2.11.2 Biomerics Major Business
        2.11.3 Biomerics Structural Heart Disease Interventional Therapy Product and Services
        2.11.4 Biomerics Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Biomerics Recent Developments/Updates
    2.12 LivaNova PLC
        2.12.1 LivaNova PLC Details
        2.12.2 LivaNova PLC Major Business
        2.12.3 LivaNova PLC Structural Heart Disease Interventional Therapy Product and Services
        2.12.4 LivaNova PLC Structural Heart Disease Interventional Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 LivaNova PLC Recent Developments/Updates

3 Competitive Environment: Structural Heart Disease Interventional Therapy by Manufacturer
    3.1 Global Structural Heart Disease Interventional Therapy Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Structural Heart Disease Interventional Therapy Revenue by Manufacturer (2018-2023)
    3.3 Global Structural Heart Disease Interventional Therapy Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Structural Heart Disease Interventional Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Structural Heart Disease Interventional Therapy Manufacturer Market Share in 2022
        3.4.2 Top 6 Structural Heart Disease Interventional Therapy Manufacturer Market Share in 2022
    3.5 Structural Heart Disease Interventional Therapy Market: Overall Company Footprint Analysis
        3.5.1 Structural Heart Disease Interventional Therapy Market: Region Footprint
        3.5.2 Structural Heart Disease Interventional Therapy Market: Company Product Type Footprint
        3.5.3 Structural Heart Disease Interventional Therapy Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Structural Heart Disease Interventional Therapy Market Size by Region
        4.1.1 Global Structural Heart Disease Interventional Therapy Sales Quantity by Region (2018-2029)
        4.1.2 Global Structural Heart Disease Interventional Therapy Consumption Value by Region (2018-2029)
        4.1.3 Global Structural Heart Disease Interventional Therapy Average Price by Region (2018-2029)
    4.2 North America Structural Heart Disease Interventional Therapy Consumption Value (2018-2029)
    4.3 Europe Structural Heart Disease Interventional Therapy Consumption Value (2018-2029)
    4.4 Asia-Pacific Structural Heart Disease Interventional Therapy Consumption Value (2018-2029)
    4.5 South America Structural Heart Disease Interventional Therapy Consumption Value (2018-2029)
    4.6 Middle East and Africa Structural Heart Disease Interventional Therapy Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2029)
    5.2 Global Structural Heart Disease Interventional Therapy Consumption Value by Type (2018-2029)
    5.3 Global Structural Heart Disease Interventional Therapy Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2029)
    6.2 Global Structural Heart Disease Interventional Therapy Consumption Value by Application (2018-2029)
    6.3 Global Structural Heart Disease Interventional Therapy Average Price by Application (2018-2029)

7 North America
    7.1 North America Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2029)
    7.2 North America Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2029)
    7.3 North America Structural Heart Disease Interventional Therapy Market Size by Country
        7.3.1 North America Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2029)
        7.3.2 North America Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2029)
    8.2 Europe Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2029)
    8.3 Europe Structural Heart Disease Interventional Therapy Market Size by Country
        8.3.1 Europe Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2029)
        8.3.2 Europe Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Structural Heart Disease Interventional Therapy Market Size by Region
        9.3.1 Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Structural Heart Disease Interventional Therapy Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2029)
    10.2 South America Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2029)
    10.3 South America Structural Heart Disease Interventional Therapy Market Size by Country
        10.3.1 South America Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2029)
        10.3.2 South America Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Structural Heart Disease Interventional Therapy Market Size by Country
        11.3.1 Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Structural Heart Disease Interventional Therapy Market Drivers
    12.2 Structural Heart Disease Interventional Therapy Market Restraints
    12.3 Structural Heart Disease Interventional Therapy Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Structural Heart Disease Interventional Therapy and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Structural Heart Disease Interventional Therapy
    13.3 Structural Heart Disease Interventional Therapy Production Process
    13.4 Structural Heart Disease Interventional Therapy Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Structural Heart Disease Interventional Therapy Typical Distributors
    14.3 Structural Heart Disease Interventional Therapy Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Structural Heart Disease Interventional Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Structural Heart Disease Interventional Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Abbott Structural Heart Basic Information, Manufacturing Base and Competitors
    Table 4. Abbott Structural Heart Major Business
    Table 5. Abbott Structural Heart Structural Heart Disease Interventional Therapy Product and Services
    Table 6. Abbott Structural Heart Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Abbott Structural Heart Recent Developments/Updates
    Table 8. philips Basic Information, Manufacturing Base and Competitors
    Table 9. philips Major Business
    Table 10. philips Structural Heart Disease Interventional Therapy Product and Services
    Table 11. philips Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. philips Recent Developments/Updates
    Table 13. Japen Lifeline Basic Information, Manufacturing Base and Competitors
    Table 14. Japen Lifeline Major Business
    Table 15. Japen Lifeline Structural Heart Disease Interventional Therapy Product and Services
    Table 16. Japen Lifeline Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Japen Lifeline Recent Developments/Updates
    Table 18. Neovasc Basic Information, Manufacturing Base and Competitors
    Table 19. Neovasc Major Business
    Table 20. Neovasc Structural Heart Disease Interventional Therapy Product and Services
    Table 21. Neovasc Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Neovasc Recent Developments/Updates
    Table 23. Append Medical Basic Information, Manufacturing Base and Competitors
    Table 24. Append Medical Major Business
    Table 25. Append Medical Structural Heart Disease Interventional Therapy Product and Services
    Table 26. Append Medical Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Append Medical Recent Developments/Updates
    Table 28. Transverse Medical Basic Information, Manufacturing Base and Competitors
    Table 29. Transverse Medical Major Business
    Table 30. Transverse Medical Structural Heart Disease Interventional Therapy Product and Services
    Table 31. Transverse Medical Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Transverse Medical Recent Developments/Updates
    Table 33. Cardiomech Basic Information, Manufacturing Base and Competitors
    Table 34. Cardiomech Major Business
    Table 35. Cardiomech Structural Heart Disease Interventional Therapy Product and Services
    Table 36. Cardiomech Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Cardiomech Recent Developments/Updates
    Table 38. Thubrikar Aortic Valve Inc. Basic Information, Manufacturing Base and Competitors
    Table 39. Thubrikar Aortic Valve Inc. Major Business
    Table 40. Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Product and Services
    Table 41. Thubrikar Aortic Valve Inc. Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Thubrikar Aortic Valve Inc. Recent Developments/Updates
    Table 43. boston scientific Basic Information, Manufacturing Base and Competitors
    Table 44. boston scientific Major Business
    Table 45. boston scientific Structural Heart Disease Interventional Therapy Product and Services
    Table 46. boston scientific Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. boston scientific Recent Developments/Updates
    Table 48. Edwards Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
    Table 49. Edwards Lifesciences Corporation Major Business
    Table 50. Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Product and Services
    Table 51. Edwards Lifesciences Corporation Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Edwards Lifesciences Corporation Recent Developments/Updates
    Table 53. Biomerics Basic Information, Manufacturing Base and Competitors
    Table 54. Biomerics Major Business
    Table 55. Biomerics Structural Heart Disease Interventional Therapy Product and Services
    Table 56. Biomerics Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Biomerics Recent Developments/Updates
    Table 58. LivaNova PLC Basic Information, Manufacturing Base and Competitors
    Table 59. LivaNova PLC Major Business
    Table 60. LivaNova PLC Structural Heart Disease Interventional Therapy Product and Services
    Table 61. LivaNova PLC Structural Heart Disease Interventional Therapy Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. LivaNova PLC Recent Developments/Updates
    Table 63. Global Structural Heart Disease Interventional Therapy Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 64. Global Structural Heart Disease Interventional Therapy Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 65. Global Structural Heart Disease Interventional Therapy Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 66. Market Position of Manufacturers in Structural Heart Disease Interventional Therapy, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 67. Head Office and Structural Heart Disease Interventional Therapy Production Site of Key Manufacturer
    Table 68. Structural Heart Disease Interventional Therapy Market: Company Product Type Footprint
    Table 69. Structural Heart Disease Interventional Therapy Market: Company Product Application Footprint
    Table 70. Structural Heart Disease Interventional Therapy New Market Entrants and Barriers to Market Entry
    Table 71. Structural Heart Disease Interventional Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Structural Heart Disease Interventional Therapy Sales Quantity by Region (2018-2023) & (K Units)
    Table 73. Global Structural Heart Disease Interventional Therapy Sales Quantity by Region (2024-2029) & (K Units)
    Table 74. Global Structural Heart Disease Interventional Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 75. Global Structural Heart Disease Interventional Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 76. Global Structural Heart Disease Interventional Therapy Average Price by Region (2018-2023) & (US$/Unit)
    Table 77. Global Structural Heart Disease Interventional Therapy Average Price by Region (2024-2029) & (US$/Unit)
    Table 78. Global Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Global Structural Heart Disease Interventional Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Global Structural Heart Disease Interventional Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Global Structural Heart Disease Interventional Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Global Structural Heart Disease Interventional Therapy Average Price by Type (2018-2023) & (US$/Unit)
    Table 83. Global Structural Heart Disease Interventional Therapy Average Price by Type (2024-2029) & (US$/Unit)
    Table 84. Global Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 85. Global Structural Heart Disease Interventional Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 86. Global Structural Heart Disease Interventional Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. Global Structural Heart Disease Interventional Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. Global Structural Heart Disease Interventional Therapy Average Price by Application (2018-2023) & (US$/Unit)
    Table 89. Global Structural Heart Disease Interventional Therapy Average Price by Application (2024-2029) & (US$/Unit)
    Table 90. North America Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 91. North America Structural Heart Disease Interventional Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 92. North America Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 93. North America Structural Heart Disease Interventional Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 94. North America Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2023) & (K Units)
    Table 95. North America Structural Heart Disease Interventional Therapy Sales Quantity by Country (2024-2029) & (K Units)
    Table 96. North America Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. North America Structural Heart Disease Interventional Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Europe Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 99. Europe Structural Heart Disease Interventional Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 100. Europe Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 101. Europe Structural Heart Disease Interventional Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 102. Europe Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2023) & (K Units)
    Table 103. Europe Structural Heart Disease Interventional Therapy Sales Quantity by Country (2024-2029) & (K Units)
    Table 104. Europe Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Structural Heart Disease Interventional Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 107. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 108. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 109. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 110. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Region (2018-2023) & (K Units)
    Table 111. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity by Region (2024-2029) & (K Units)
    Table 112. Asia-Pacific Structural Heart Disease Interventional Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 113. Asia-Pacific Structural Heart Disease Interventional Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 114. South America Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 115. South America Structural Heart Disease Interventional Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 116. South America Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 117. South America Structural Heart Disease Interventional Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 118. South America Structural Heart Disease Interventional Therapy Sales Quantity by Country (2018-2023) & (K Units)
    Table 119. South America Structural Heart Disease Interventional Therapy Sales Quantity by Country (2024-2029) & (K Units)
    Table 120. South America Structural Heart Disease Interventional Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 121. South America Structural Heart Disease Interventional Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Type (2018-2023) & (K Units)
    Table 123. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Type (2024-2029) & (K Units)
    Table 124. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Application (2018-2023) & (K Units)
    Table 125. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Application (2024-2029) & (K Units)
    Table 126. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Region (2018-2023) & (K Units)
    Table 127. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity by Region (2024-2029) & (K Units)
    Table 128. Middle East & Africa Structural Heart Disease Interventional Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Structural Heart Disease Interventional Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 130. Structural Heart Disease Interventional Therapy Raw Material
    Table 131. Key Manufacturers of Structural Heart Disease Interventional Therapy Raw Materials
    Table 132. Structural Heart Disease Interventional Therapy Typical Distributors
    Table 133. Structural Heart Disease Interventional Therapy Typical Customers
List of Figures
    Figure 1. Structural Heart Disease Interventional Therapy Picture
    Figure 2. Global Structural Heart Disease Interventional Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Structural Heart Disease Interventional Therapy Consumption Value Market Share by Type in 2022
    Figure 4. Equipment Examples
    Figure 5. Consumables Examples
    Figure 6. Global Structural Heart Disease Interventional Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Structural Heart Disease Interventional Therapy Consumption Value Market Share by Application in 2022
    Figure 8. Hospital Examples
    Figure 9. Clinic Examples
    Figure 10. Others Examples
    Figure 11. Global Structural Heart Disease Interventional Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Structural Heart Disease Interventional Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Structural Heart Disease Interventional Therapy Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Structural Heart Disease Interventional Therapy Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Structural Heart Disease Interventional Therapy Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Structural Heart Disease Interventional Therapy by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Structural Heart Disease Interventional Therapy Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Structural Heart Disease Interventional Therapy Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Structural Heart Disease Interventional Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Structural Heart Disease Interventional Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Structural Heart Disease Interventional Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Structural Heart Disease Interventional Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Structural Heart Disease Interventional Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Structural Heart Disease Interventional Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Structural Heart Disease Interventional Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Structural Heart Disease Interventional Therapy Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Structural Heart Disease Interventional Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Structural Heart Disease Interventional Therapy Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Structural Heart Disease Interventional Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Structural Heart Disease Interventional Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Structural Heart Disease Interventional Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Structural Heart Disease Interventional Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Structural Heart Disease Interventional Therapy Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Structural Heart Disease Interventional Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Structural Heart Disease Interventional Therapy Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Structural Heart Disease Interventional Therapy Market Drivers
    Figure 74. Structural Heart Disease Interventional Therapy Market Restraints
    Figure 75. Structural Heart Disease Interventional Therapy Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Structural Heart Disease Interventional Therapy in 2022
    Figure 78. Manufacturing Process Analysis of Structural Heart Disease Interventional Therapy
    Figure 79. Structural Heart Disease Interventional Therapy Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Abbott Structural Heart
philips
Japen Lifeline
Neovasc
Append Medical
Transverse Medical
Cardiomech
Thubrikar Aortic Valve Inc.
boston scientific
Edwards Lifesciences Corporation
Biomerics
LivaNova PLC

Related Reports

Global Structural Heart Disease Interventional Therapy Supply, Demand and Key Producers, 2023-2029

Global Structural Heart Disease Interventional Therapy Supply, Demand and Key Producers, 2023-2029

date 01 Jun 2023

date Medical Devices & Consumables

The global Structural Heart Disease Interventional Therapy market size is expected to reach $ 27720 million by 2029, rising at a market growth of 10.3% CAGR during the forecast period (2023-2029).

Global Structural Heart Disease Interventional Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Structural Heart Disease Interventional Therapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 29 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Structural Heart Disease Interventional Therapy market size was valued at USD 13920 million in 2023 and is forecast to a readjusted size of USD 27720 million by 2030 with a CAGR of 10.3% during review period.

Global Structural Heart Disease Interventional Therapy Supply, Demand and Key Producers, 2024-2030

Global Structural Heart Disease Interventional Therapy Supply, Demand and Key Producers, 2024-2030

date 02 Mar 2024

date Medical Devices & Consumables

The global Structural Heart Disease Interventional Therapy market size is expected to reach $ 27720 million by 2030, rising at a market growth of 10.3% CAGR during the forecast period (2024-2030).

Product Tags

Structural Heart Disease Interventional Therapy

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>